4//SEC Filing
Kjems Lise Lund 4
Accession 0001437749-21-022725
CIK 0000922247other
Filed
Sep 27, 8:00 PM ET
Accepted
Sep 28, 9:47 AM ET
Size
6.6 KB
Accession
0001437749-21-022725
Insider Transaction Report
Form 4
Kjems Lise Lund
Chief Medical Officer
Transactions
- Award
Common Stock
2021-09-27+17,053→ 17,053 total - Award
Stock Option (Right to buy)
2021-09-27+23,800→ 23,800 totalExercise: $7.33Exp: 2031-09-27→ Common Stock (23,800 underlying)
Footnotes (1)
- [F1]The option vests immediately with respect to one-quarter of the shares of common stock subject to the option, and vests with respect to the remaining shares over a four-year period in 48 equal monthly installments on the first day of each month following the date of grant.
Documents
Issuer
Cyclo Therapeutics, Inc.
CIK 0000922247
Entity typeother
Related Parties
1- filerCIK 0001884844
Filing Metadata
- Form type
- 4
- Filed
- Sep 27, 8:00 PM ET
- Accepted
- Sep 28, 9:47 AM ET
- Size
- 6.6 KB